Communicating risk: Does scientific debate compromise safety?

Contraception

Volumn 86, Issue 4, 2012, Pages 327-329

  Jensen, Jeffrey T ^a   Trussell, James ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATTRIBUTABLE RISK; CONTRACEPTION; HUMAN; INTERPERSONAL COMMUNICATION; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL INFORMATION; MORTALITY; PATIENT CARE; PATIENT COUNSELING; REVIEW; SAFETY; UNPLANNED PREGNANCY; VEIN THROMBOSIS;

EID: 84866015097     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.06.010     Document Type: Editorial

References (15)

1. O. Lidegaard, L.H. Nielsen, C.W. Skovlund, and E. Lokkegaard Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 BMJ 344 2012 e2990
2. O. Lidegaard, E. Lokkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
3. J. Trussell, and K.A. Guthrie Choosing a contraceptive: efficacy, safety, and personal considerations R.A. Hatcher, J. Trussell, A.L. Nelson, W. Cates Jr. D. Kowal, M. Policar, Contraceptive technology 2011 Ardent Media New York
4. W.M. Callaghan Overview of maternal mortality in the United States Semin Perinatol 36 2012 2 6
5. MMWR Motor vehicle-related death rates - United States, 1999-2005 Morb Mortal Wkly Rep 58 2009 161 165
6. M. Vessey, D. Yeates, and S. Flynn Factors affecting mortality in a large cohort study with special reference to oral contraceptive use Contraception 82 2010 221 229
7. K. Heinemann, and L.A. Heinemann Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel J Fam Plann Reprod Health Care 37 2011 132 135
8. S. Shapiro, and J. Dinger Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies J Fam Plann Reprod Health Care 36 2010 33 38
9. J.C. Dinger, L.A. Heinemann, and D. Kuhl-Habich The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation Contraception 75 2007 344 354
10. British Medical Journal rapid responses. Available at: http://www.bmj.com/content/344/bmj.e2990?tab=responses. (date accessed 10 June 2012).
11. J.C. Dinger, K. Bardenheuer, and A. Assmann International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study) BMC Med Res Methodol 9 2009 77
12. Bayer Healthcare Pharmaceuticals drospirenone-containing combination oral contraceptives briefing document. Available at: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ ReproductiveHealthDrugsAdvisoryCommittee/UCM282464.pdf. (date accessed: 10 June 2012).
13. J.D. Seeger, J. Loughlin, P.M. Eng, C.R. Clifford, J. Cutone, and A.M. Walker Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives Obstet Gynecol 110 2007 587 593
14. Dinger JC, Pineda AA. Risk of VTE in users of an etonogestrel-containing vaginal ring and combined oral contraceptives (abstract presented at the 61st Annual ACOG meeting). Available at: http://classic.acog.org/acm/pdf/oralMon748. pdf. (date accessed 10 June 2012).
15. K.M. Curtis, D.J. Jamieson, H.B. Peterson, and P.A. Marchbanks Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States Contraception 82 2010 3 9